Advisory Council for the Elimination of Tuberculosis, 62112 [E6-17652]
Download as PDF
<![CDATA[
62112
Federal Register / Vol. 71, No. 204 / Monday, October 23, 2006 / Notices
the NTP BSC (see FOR FURTHER
INFORMATION CONTACT above) by
November 17, 2006, to enable review by
the NTP BSC and NIEHS/NTP staff prior
to the meeting. Written statements can
supplement and may expand the oral
presentation. If registering on-site and
reading from written text, please bring
40 copies of the statement for
distribution to the NTP BSC and NIEHS/
NTP staff and to supplement the record.
Written comments received in
response to this notice will be posted on
the NTP Web site. Persons submitting
written comments should include their
name, affiliation, mailing address,
phone, fax, e-mail, and sponsoring
organization (if any) with the document.
Background Information on the NTP
Board of Scientific Counselors
The NTP BSC is a technical advisory
body comprised of scientists from the
public and private sectors who provide
primary scientific oversight to the
overall program and its centers.
Specifically, the NTP BSC advises the
NTP on matters of scientific program
content, both present and future, and
conducts periodic review of the program
for the purposes of determining and
advising on the scientific merit of its
activities and their overall scientific
quality. Its members are selected from
recognized authorities knowledgeable in
fields such as toxicology, pharmacology,
pathology, biochemistry, epidemiology,
risk assessment, carcinogenesis,
mutagenesis, molecular biology,
behavioral toxicology and
neurotoxicology, immunotoxicology,
reproductive toxicology or teratology,
and biostatistics. Members serve
overlapping terms of up to four years.
NTP BSC meetings are held annually or
biannually.
Dated: October 13, 2006.
Samuel A. Wilson,
Deputy Director, National Institute of
Environmental Health Sciences and National
Toxicology Program.
[FR Doc. E6–17711 Filed 10–20–06; 8:45 am]
Control and Prevention (CDC)
announces the following meeting.
Name: Healthcare Infection Control
Practices Advisory Committee (HICPAC).
Times And Dates: 8:30 a.m.–5 p.m.,
November 13, 2006; 8:30 a.m.–4 p.m.,
November 14, 2006.
Place: CDC Roybal Campus, Bldg 19,
Auditorium B3, 1600 Clifton Road, Atlanta,
GA 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, the Assistant Secretary for Health,
the Director, CDC, and the Director, National
Center for Infectious Diseases (NCID),
regarding (1) the practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: Agenda items
will include: Issues related to public
reporting of healthcare-associated infection
rates; Infection control for multi-drug
resistant organisms; and, topics related to
future guidelines.
Agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Harriette Lynch, Committee Management
Specialist, HICPAC, Division of Healthcare
Quality Promotion, NCID, CDC, l600 Clifton
Road, NE., M/S A–07, Atlanta, Georgia
30333, telephone 404/639–4035.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 16, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–17660 Filed 10–20–06; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4140–01–P
mstockstill on PROD1PC76 with NOTICES
Healthcare Infection Control Practices
Advisory Committee (HICPAC):
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Jkt 211001
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
15:50 Oct 20, 2006
Dated: October 16, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–17652 Filed 10–20–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
Name: Advisory Council for the
Elimination of Tuberculosis (ACET).
Times and Dates: 8:30 a.m.–5 p.m.,
December 5, 2006; 8:30 a.m.–12 p.m.,
December 6, 2006.
Place: Corporate Square, Building 8,
1st Floor Conference Room, Atlanta,
Georgia 30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 100
people.
Purpose: This council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis (TB).
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating TB.
Matters to be Discussed: Agenda items
include issues pertaining to Emerging
Global issues in TB Surveillance and
Control; XDR-TB: Implications for TB
control in the U.S.; TB among Foreignborn and other related tuberculosis
issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Loretta Coleman-Johnson, National
Center for HIV, STD, and TB Prevention,
1600 Clifton Road, NE., M/S E–10,
Atlanta, Georgia 30333, Telephone 404/
639–8120.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council for the Elimination of
Tuberculosis
Health Resources and Services
Administration
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following council
meeting:
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Periodically, the Health Resources
and Services Administration (HRSA)
E:\FR\FM\23OCN1.SGM
23OCN1
]]>Agencies
[Federal Register Volume 71, Number 204 (Monday, October 23, 2006)]
[Notices]
[Page 62112]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-17652]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following council meeting:
Name: Advisory Council for the Elimination of Tuberculosis (ACET).
Times and Dates: 8:30 a.m.-5 p.m., December 5, 2006; 8:30 a.m.-12
p.m., December 6, 2006.
Place: Corporate Square, Building 8, 1st Floor Conference Room,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis (TB). Specifically, the Council makes recommendations
regarding policies, strategies, objectives, and priorities; addresses
the development and application of new technologies; and reviews the
extent to which progress has been made toward eliminating TB.
Matters to be Discussed: Agenda items include issues pertaining to
Emerging Global issues in TB Surveillance and Control; XDR-TB:
Implications for TB control in the U.S.; TB among Foreign-born and
other related tuberculosis issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Loretta Coleman-Johnson,
National Center for HIV, STD, and TB Prevention, 1600 Clifton Road,
NE., M/S E-10, Atlanta, Georgia 30333, Telephone 404/639-8120.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: October 16, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-17652 Filed 10-20-06; 8:45 am]
BILLING CODE 4163-18-P
